These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 12680223

  • 1. Induction mechanism of apoptosis by troglitazone through peroxisome proliferator-activated receptor-gamma in gastric carcinoma cells.
    Yoshida K, Tanabe K, Fujii D, Oue N, Yasui W, Toge T.
    Anticancer Res; 2003; 23(1A):267-73. PubMed ID: 12680223
    [Abstract] [Full Text] [Related]

  • 2. Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells.
    Motomura W, Okumura T, Takahashi N, Obara T, Kohgo Y.
    Cancer Res; 2000 Oct 01; 60(19):5558-64. PubMed ID: 11034103
    [Abstract] [Full Text] [Related]

  • 3. The ligands of peroxisome proliferator-activated receptor (PPAR) gamma inhibit growth of human esophageal carcinoma cells through induction of apoptosis and cell cycle arrest.
    Fujii D, Yoshida K, Tanabe K, Hihara J, Toge T.
    Anticancer Res; 2004 Oct 01; 24(3a):1409-16. PubMed ID: 15274302
    [Abstract] [Full Text] [Related]

  • 4. Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines.
    Yoshizawa K, Cioca DP, Kawa S, Tanaka E, Kiyosawa K.
    Cancer; 2002 Nov 15; 95(10):2243-51. PubMed ID: 12412180
    [Abstract] [Full Text] [Related]

  • 5. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.
    Kubota T, Koshizuka K, Williamson EA, Asou H, Said JW, Holden S, Miyoshi I, Koeffler HP.
    Cancer Res; 1998 Aug 01; 58(15):3344-52. PubMed ID: 9699665
    [Abstract] [Full Text] [Related]

  • 6. Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells.
    Laurora S, Pizzimenti S, Briatore F, Fraioli A, Maggio M, Reffo P, Ferretti C, Dianzani MU, Barrera G.
    J Pharmacol Exp Ther; 2003 Jun 01; 305(3):932-42. PubMed ID: 12649303
    [Abstract] [Full Text] [Related]

  • 7. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
    Yang FG, Zhang ZW, Xin DQ, Shi CJ, Wu JP, Guo YL, Guan YF.
    Acta Pharmacol Sin; 2005 Jun 01; 26(6):753-61. PubMed ID: 15916743
    [Abstract] [Full Text] [Related]

  • 8. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
    Bruemmer D, Yin F, Liu J, Berger JP, Sakai T, Blaschke F, Fleck E, Van Herle AJ, Forman BM, Law RE.
    Circ Res; 2003 Aug 22; 93(4):e38-47. PubMed ID: 12881480
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis.
    Tsubouchi Y, Sano H, Kawahito Y, Mukai S, Yamada R, Kohno M, Inoue K, Hla T, Kondo M.
    Biochem Biophys Res Commun; 2000 Apr 13; 270(2):400-5. PubMed ID: 10753637
    [Abstract] [Full Text] [Related]

  • 10. Troglitazone induces G1 arrest by p27(Kip1) induction that is mediated by inhibition of proteasome in human gastric cancer cells.
    Takeuchi S, Okumura T, Motomura W, Nagamine M, Takahashi N, Kohgo Y.
    Jpn J Cancer Res; 2002 Jul 13; 93(7):774-82. PubMed ID: 12149143
    [Abstract] [Full Text] [Related]

  • 11. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo.
    Yu J, Qiao L, Zimmermann L, Ebert MP, Zhang H, Lin W, Röcken C, Malfertheiner P, Farrell GC.
    Hepatology; 2006 Jan 13; 43(1):134-43. PubMed ID: 16374840
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effect of peroxisome proliferator-activated receptor-gamma ligand on urological cancer cells.
    Yoshimura R, Matsuyama M, Hase T, Tsuchida K, Kuratsukuri K, Kawahito Y, Sano H, Segawa Y, Nakatani T.
    Int J Mol Med; 2003 Dec 13; 12(6):861-5. PubMed ID: 14612958
    [Abstract] [Full Text] [Related]

  • 15. PPARgamma inhibits the expression of c-MET in human gastric cancer cells through the suppression of Ets.
    Kitamura S, Miyazaki Y, Hiraoka S, Toyota M, Nagasawa Y, Kondo S, Kiyohara T, Shinomura Y, Matsuzawa Y.
    Biochem Biophys Res Commun; 1999 Nov 19; 265(2):453-6. PubMed ID: 10558888
    [Abstract] [Full Text] [Related]

  • 16. Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice.
    Osawa E, Nakajima A, Wada K, Ishimine S, Fujisawa N, Kawamori T, Matsuhashi N, Kadowaki T, Ochiai M, Sekihara H, Nakagama H.
    Gastroenterology; 2003 Feb 19; 124(2):361-7. PubMed ID: 12557142
    [Abstract] [Full Text] [Related]

  • 17. Expression of peroxisome proliferator-activated receptor (PPAR)gamma in gastric cancer and inhibitory effects of PPARgamma agonists.
    Sato H, Ishihara S, Kawashima K, Moriyama N, Suetsugu H, Kazumori H, Okuyama T, Rumi MA, Fukuda R, Nagasue N, Kinoshita Y.
    Br J Cancer; 2000 Nov 19; 83(10):1394-400. PubMed ID: 11044367
    [Abstract] [Full Text] [Related]

  • 18. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells.
    Ohta K, Endo T, Haraguchi K, Hershman JM, Onaya T.
    J Clin Endocrinol Metab; 2001 May 19; 86(5):2170-7. PubMed ID: 11344222
    [Abstract] [Full Text] [Related]

  • 19. PPARgamma ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21 pathway.
    Han C, Demetris AJ, Michalopoulos GK, Zhan Q, Shelhamer JH, Wu T.
    Hepatology; 2003 Jul 19; 38(1):167-77. PubMed ID: 12829999
    [Abstract] [Full Text] [Related]

  • 20. PPAR gamma ligand-induced apoptosis through a p53-dependent mechanism in human gastric cancer cells.
    Nagamine M, Okumura T, Tanno S, Sawamukai M, Motomura W, Takahashi N, Kohgo Y.
    Cancer Sci; 2003 Apr 19; 94(4):338-43. PubMed ID: 12824901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.